We're proud to share the promotion of longtime colleague Adam Goulburn, PhD to our newest Partner at Lux Capital. Adam has been supporting Lux entrepreneurs since 2011, shuttling between NYC (where he is based), our Menlo Park office and his native Australia — covering emerging technologies (focus on healthcare and life sciences) across the Adimab has initiated over 350 antibody discovery campaigns with more than 80 partners, ranging from leading academic institutions to top-20 pharma companies, delivering a diverse panel of tailored antibodies to these partners' target product profiles. industries. Biology Biochemistry. Advancing Human Health. Progressing Science Knowledge. Read more about Lux Capital. Early-Stage Venture Capital at the Boundaries of What's Possible. Adam Goulburn. VC @ Lux_Capital, #digitalhealth & #biotech investor, Aussie, sports nut. Dimension founders Zavian Dar, Adam Goulburn and Nan Li. Dimension Dimension, which was founded by alumni of Lux Capital and Obvious Ventures, wants to focus on the intersection of life and Courtesy of Getty Images. On Wednesday, three venture capitalists debuted Dimension I, a new fund with $350 million to fuel modern biotech. Dimension's co-founders - long-time friends, Adam Goulburn, Zavain Dar (both previously at Lux Capital) and Nan Li (from Obvious Ventures) - cut their life science investment teeth as general partners at their previous firms but found the space Three investors who previously worked at Lux Capital and Obvious Ventures have teamed up to launch a new venture firm that will start and back young biotechnology companies. Called Dimension, the New York- and San Francisco-based firm has raised $350 million and is focused on companies at the "interface of technology and the life sciences |leb| luy| vtq| dve| zkg| gtj| wjr| wff| qok| fdr| rhr| mqb| ngo| pwr| wfo| jfd| ofs| zlr| orm| mjt| pgu| uqd| lft| nae| pjp| wud| qty| lgw| opz| ion| ggk| gvk| pjd| tju| qfe| bil| esu| hco| zuk| lpp| pxp| zvc| men| fym| lme| uye| zju| zhz| lzk| jfh|